Advertisement
Advertisement
U.S. markets close in 45 minutes
Advertisement
Advertisement
Advertisement
Advertisement

MariMed Inc. (MRMD)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.62000.0000 (0.00%)
As of 02:57PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6200
Open0.6110
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5900 - 0.6898
52 Week Range0.4000 - 1.2000
Volume353,917
Avg. Volume560,506
Market Cap208.192M
Beta (5Y Monthly)3.34
PE Ratio (TTM)31.00
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MRMD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MARIMED INC
    Analyst Report: Curaleaf Holdings, Inc.Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 22 states, including the assets from the Cura Select and Grassroots acquisitions. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
    Rating
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more
  • GlobeNewswire

    MariMed Strengthens Executive Leadership Team To Support Accelerated Long-Term Growth

    Jon Levine Elevated to Chief Administration OfficerSusan Villare Appointed Chief Financial Officer NORWOOD, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced the appointment of Jon Levine to the new role of Chief Administration Officer (“CAO”) and the appointment of Susan Villare to Chief Financial Officer (“CFO”) effective May 12, 2022. Strengthening MariM

  • GlobeNewswire

    MariMed Reports First Quarter 2022 Earnings

    Revenue Grew 27% Year Over Year Non-GAAP Adjusted EBITDA Grew 29% Year Over Year Company Maintains Full Year 2022 Guidance NORWOOD, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2022. “I am very pleased with our solid financial results this past quarter despite a slowdown in our industry coupl

  • GlobeNewswire

    MariMed Closes Acquisition of Illinois Craft Cannabis License Allowing for Vertically Integrated Operations

    NORWOOD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced it has closed its acquisition of Green Growth Group, Inc. (“Green Growth”). The close of this transaction enables MariMed to add cultivation, manufacturing, and distribution to its existing retail cannabis operations in Illinois. MariMed will bring its full product portfolio of award-winning and to

Advertisement
Advertisement